Products Categories
    Product Certification&
    Enterprise Certification

  • Ms.Zhang
    Tel: +8613581984929

  • Mobile:+8613581984929
  • Tel:+8613581984929
  • Fax:
  • Province/state:Beijing
  • City:Beijing
  • Street:Beijing
  • MaxCard:
Home > Products >  2-Methyladenosine

2-Methyladenosine CAS NO.16526-56-0

  • Min.Order: 1 Gram
  • Payment Terms: T/T,MoneyGram,Other
  • Product Details

Keywords

  • 16526-56-0
  • 2-Methyladenosine
  • in stock

Quick Details

  • ProName: 2-Methyladenosine
  • CasNo: 16526-56-0
  • Molecular Formula: C11H15N5O4
  • Appearance: White solid powder
  • Application: For research and production.
  • DeliveryTime: 1-2 days
  • PackAge: As required
  • Port: For research and production.
  • ProductionCapacity: 1 Kilogram/Month
  • Purity: 97%
  • Storage: Dry, dark and at 0 - 4 C for short ter...
  • Transportation: Shipped under ambient temperature as n...
  • LimitNum: 1 Gram

Superiority

Talampanel (97%) is in stock. The same day ship out after order is received. Delivery time: overnight (China mainland); 3-5 days (worldwide).This is our mature product with high quality and competitive price. Welcome your inquiry and order. Also, we would like to develop strategic partnership with our clients.

Details

CAS No.:16526-56-0

LAL ID:xqy-170208

Chemical Names: 2-Methyladenosine; Adenosine, 2-methyl-; 16526-56-0;

Molecular Formula: C11H15N5O4

Molecular Weight: 281.272 g/mol

Purity: 97%

Description: Talampanel, also known as LY300164 and GYKI-53773, is a glutamate receptor inhibitor with anti-seizure activity. Talampanel is also an orally active, potent and selective AMPA-receptor antagonist, and can noncompetitively bind to the AMPA subtype of glutamate excitatory amino acid receptors and may inhibit the growth of gliomas by interfering with neurotransmitters involved in brain tumor growth. This agent may also protect against traumatic brain injury. Talampanel (GYKI 53405) is being investigated for the treatment of epilepsy, malignant gliomas and amyotrophic lateral sclerosis (ALS). As of May 2010, results from the trial for ALS have been found negative.

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog